Sugi Predict

Sugi Predict / Compounds / SCHEMBL2990838

SCHEMBL2990838

SCHEMBL2990838

CC(C)(C)[Si](C)(C)OC[C@H]1CC[C@@H](N2CCC(Cc3ccc(Cl)cc3Cl)C2=O)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 6/20 0.35
▸ HSD11B1 P28845 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CCR3 P51677 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ GPBAR1 Q8TDU6 1/20 0.32
▸ TRPV4 Q9HBA0 1/20 0.32
▸ FFAR1 O14842 2/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13241760 1.00 P2RX7 (0.35) P2RX7HSD11B1TSHRHTTMEN1
SCHEMBL2990005 0.91 HSD11B1 (0.33) HSD11B1
SCHEMBL13241764 0.91 HSD11B1 (0.33) HSD11B1
SCHEMBL2992128 0.87 P2RX7 (0.36) P2RX7HSD11B1TSHRHTTMEN1
SCHEMBL2992129 0.87 P2RX7 (0.36) P2RX7HSD11B1TSHRHTTMEN1
SCHEMBL2996004 0.80 P2RX7 (0.43) P2RX7HSD11B1CCR3GPBAR1FFAR1
SCHEMBL2992277 0.80 P2RX7 (0.43) P2RX7HSD11B1CCR3GPBAR1FFAR1
SCHEMBL2993666 0.79 HSD11B1 (0.40) P2RX7HSD11B1MEN1KMT2ACCR3
SCHEMBL2993670 0.79 HSD11B1 (0.40) P2RX7HSD11B1MEN1KMT2ACCR3
SCHEMBL4525741 0.78 HSD11B1 (0.41) P2RX7HSD11B1MAPTCCR3GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2010-07-22 — — US disclosed
US-7713979-B2 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-05-11 — — US disclosed
EP-1807072-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2009-01-07 — — EP disclosed
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSDL2, HSD17B1 P2RX7 3884/4885HSD11B1 1/4885TSHR 4029/4885
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 P2RX7 4250/4885HSD11B1 1/4885TSHR 4108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.